[1]
D. Maharajan P., T. J. Singh, S. B. Devi, H. R. Singh, D. R. Paul, and J. L., “Profile of patients undergoing third line anti-retroviral therapy”, Int J Adv Med, vol. 7, no. 9, pp. 1394–1399, Aug. 2020.